Your browser doesn't support javascript.
loading
Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1.
Sanz, Marta; Weideman, Ann Marie K; Ward, Adam R; Clohosey, Matthew L; Garcia-Recio, Susana; Selitsky, Sara R; Mann, Brendan T; Iannone, Marie Anne; Whitworth, Chloe P; Chitrakar, Alisha; Garrido, Carolina; Kirchherr, Jennifer; Coffey, Alisha R; Tsai, Yi-Hsuan; Samir, Shahryar; Xu, Yinyan; Copertino, Dennis; Bosque, Alberto; Jones, Brad R; Parker, Joel S; Hudgens, Michael G; Goonetilleke, Nilu; Soriano-Sarabia, Natalia.
Afiliación
  • Sanz M; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington, DC, United States.
  • Weideman AMK; Biostatistics Core, Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Ward AR; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Clohosey ML; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington, DC, United States.
  • Garcia-Recio S; Department of Infectious Diseases, Weill Cornell Medicine, New York, NY, United States.
  • Selitsky SR; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Mann BT; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Iannone MA; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Whitworth CP; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Chitrakar A; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Garrido C; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington, DC, United States.
  • Kirchherr J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Coffey AR; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Tsai YH; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington, DC, United States.
  • Samir S; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Xu Y; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Copertino D; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Bosque A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Jones BR; Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Parker JS; Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Hudgens MG; Department of Infectious Diseases, Weill Cornell Medicine, New York, NY, United States.
  • Goonetilleke N; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington, DC, United States.
  • Soriano-Sarabia N; Department of Microbiology Immunology and Tropical Medicine, the George Washington University, Washington, DC, United States.
Front Immunol ; 14: 1219250, 2023.
Article en En | MEDLINE | ID: mdl-37744358
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos